Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 36 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

39%

14 trials in Phase 3/4

Results Transparency

25%

3 of 12 completed with results

Key Signals

3 with results100% success

Data Visualizations

Phase Distribution

21Total
Not Applicable (5)
P 2 (2)
P 3 (10)
P 4 (4)

Trial Status

Completed12
Recruiting11
Not Yet Recruiting10
Unknown2
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (36)

Showing 20 of 20 trials
NCT07015905Phase 3RecruitingPrimary

REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

NCT07560293Not Yet Recruiting

3D-EIT for Diagnosis and Monitoring of Pulmonary Embolism

NCT06628778Phase 3Not Yet RecruitingPrimary

Collaborative Risk-stratified Investigation in Thrombosis-prone Inpatients With Critical Illness: Anticoagulation With LMWH in Teens for ThromboProphylaxis (CRITICAL-Teens-TP).

NCT07493304Phase 3Not Yet RecruitingPrimary

Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers

NCT07143539Not ApplicableRecruitingPrimary

Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism

NCT07439991Recruiting

Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery

NCT07432529Phase 3Not Yet Recruiting

Design and Rationale of the COLT Study

NCT07140211Phase 3RecruitingPrimary

Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis

NCT07406074Not Yet Recruiting

Duke Virtual IntEgrated Workflow

NCT07124819Phase 3Completed

Dimolegin® (60 mg) Given Once Daily in Patients Undergoing Total Hip or Knee Replacement Compared to Enoxaparin

NCT06937372Not ApplicableNot Yet Recruiting

Delivery and Implementation of a Randomised Crossover Trial on Thrombosis

NCT07310693RecruitingPrimary

External Validation of the CLOVER Score for Detecting Occult Cancer in Venous Thromboembolism Patients

NCT07288632RecruitingPrimary

Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer

NCT07228663Phase 3Not Yet Recruiting

Hip Fracture Surgery Arterial and Venous Thrombotic Events Prevention

NCT07168005Not ApplicableNot Yet RecruitingPrimary

Informative Video Before LMWH Postpartum - Randomized Controlled Trial

NCT06731673RecruitingPrimary

Heat Shock Protein 47 in Thrombosis

NCT06845423Phase 4RecruitingPrimary

Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk

NCT06958588Phase 4RecruitingPrimary

Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis

NCT02798471Phase 3CompletedPrimary

Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)

NCT06606275Completed

The Safety and Effectiveness of Warfarin Vs Apixaban in Patients with NVAF/ VTE and ESKD on Dialysis

Scroll to load more

Research Network

Activity Timeline